4//SEC Filing
Bailey Jeffrey Allen 4
Accession 0001103021-22-000020
CIK 0001103021other
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 6:00 PM ET
Size
8.4 KB
Accession
0001103021-22-000020
Insider Transaction Report
Form 4
Bailey Jeffrey Allen
DirectorChief Executive Officer
Transactions
- Award
Stock Options (right to buy)
2022-01-27$3.66/sh+1,143,467$4,185,089→ 1,143,467 totalExercise: $3.66Exp: 2032-01-26→ Common Stock (1,143,467 underlying) - Award
Restricted Stock Units
2022-01-27+204,918→ 204,918 totalExercise: $0.00Exp: 2025-01-27→ Common Stock (204,918 underlying)
Footnotes (4)
- [F1]The exercise price of the stock options issued to the Reporting Person is equal to the closing price of the Issuer's common stock on January 27, 2022.
- [F2]The stock options were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Issuer's 2019 Stock Option Incentive Plan (the "Plan"). The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025.
- [F3]The Restricted Stock Units ("RSUs") were issued to the Reporting Person on January 27, 2022, pursuant to a grant under the Plan. The award is subject to time-based vesting and will vest in equal portions on: (i) January 27, 2023; (ii) January 27, 2024; and (iii) January 27, 2025.
- [F4]Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock.
Documents
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
CIK 0001103021
Entity typeother
Related Parties
1- filerCIK 0001500210
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 6:00 PM ET
- Size
- 8.4 KB